clopidogrel has been researched along with Esophageal Perforation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuta, T; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
1 other study(ies) available for clopidogrel and Esophageal Perforation
Article | Year |
---|---|
Antiplatelet drugs are a risk factor for esophageal mucosal injury.
Topics: Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Aspirin; Case-Control Studies; Clopidogrel; Cytochrome P-450 CYP2C19; Esophageal Perforation; Esophageal pH Monitoring; Gastroesophageal Reflux; Genotype; Humans; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2013 |